Pharmacokinetics of danofloxacin 18% in lactating sheep and goats

Journal of Veterinary Pharmacology and Therapeutics

Volumn 30, Issue 6, 2007, Pages 572-577

  Escudero, E ^a,c   Carceles C M ^a   Fernandez Varon, E ^a   Marin, P ^a   Benchaoui, H ^b  

^a UNIVERSITY OF MURCIA   (Spain)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^c Campus de Espinardo   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DANOFLOXACIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; GOAT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LACTATION; MILK; NONHUMAN; PRIORITY JOURNAL; SHEEP;

ANIMALS; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; CROSS-OVER STUDIES; FEMALE; FLUOROQUINOLONES; GOATS; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; LACTATION; MILK; PREGNANCY; SHEEP;

CAPRA HIRCUS; OVIS ARIES;

EID: 35848932291     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2007.00898.x     Document Type: Article

References (30)

1. Aliabadi, F.S. Lees, P. (2001) Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration. American Journal of Veterinary Research, 62, 1979 1989.
2. Aliabadi, F.S. Lees, P. (2002) Pharmacokinetic-pharmacodynamic integration of danofloxacin in the calf. Research in Veterinary Science, 74, 247 259.
3. Aliabadi, F.S., Landoni, M.F. Lees, P. (2003) Pharmacokinetics (PK), Pharmacodynamics (PD), and PK-PD integration of danofloxacin in sheep biological fluids. Antimicrobial Agents and Chemotherapy, 47, 626 635.
4. Appelbaum, P.C. Hunter, P.A. (2000) The fluoroquinolone antibacterials: past present and future perspectives. International Journal of Antimicrobial Agents, 16, 5 15.
5. Atef, M., El-Gendi, A.Y., Aziza-Amer, M.M. El-Aty, A.M. (2001) Some pharmacokinetic data for danofloxacin in healthy goats. Veterinary Research Communications, 25, 367 377.
6. Brown, S.A. (1996) Fluoroquinolones in animal health. Journal of Veterinary Pharmacology and Therapeutics, 19, 1 14.
7. Craig, WA. (1998) Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clinical Infectious Diseases, 26, 1 10.
8. Drusano, G.L., Johnson, D.E., Rosen, M. Standiford, H.C. (1993) Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrobial Agents and Chemotherapy, 37, 483 490.
9. Fang, W. Pyörälä, S. (1996) Mastitis-causing Escherichia coli: serum sensitivity and susceptibility to selected antibacterials in milk. Journal of Dairy Science, 79, 76 82.
10. Friis, C. (1993) Penetration of danofloxacin into respiratory tract tissues and secretions in calves. American Journal of Veterinary Research, 54, 1122 1127.
11. Giles, C.J., Magonigle, R.A., Grimshaw, W.T.R., Tanner, A.C., Risk, J.E., Lynch, M.J. Rice, J.R. (1991) Clinical pharmacokinetics of administered danofloxacin in cattle. Journal of Veterinary Pharmacology and Therapeutics, 14, 400 410.
12. Godinho, K.S., Benchaoui, H.A., Tilt, N., Ramage, C., Quirie, M., Donachie, W., DelaPuente-Redondo, V. Rowan, T.G. (2007) The efficacy of danofloxacin in the treatment of pneumonic pasteurellosis in an experimental model using specific pathogen free lambs. The Veterinary Record, 160, 766 769.
13. Hannan, P.C.T., O'Hanlon, P.J. Rogers, N.M. (1989) In vitro evaluation of various quinolone antibacterials agents against veterinary mycoplasmas and porcine respiratory bacterial pathogens. Research in Veterinary Science, 46, 202 211.
14. Hannan, P.C.T., Windsor, G.D., Jong, A., Schmeer, N. Stegemann, M. (1997) Comparative susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolones. Antimicrobial Agents and Chemotherapy, 41, 2037 2040.
15. Haritova, A., Lashev, L. Pashov, D. (2003) Pharmacokinetics of enrofloxacin in lactating sheep. Research in Veterinary Science, 74, 241 245.
16. Jonker, J.W., Merino, G. Musters, S. (2005) The breast cancer resistance protein BCRP(ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nature Medicine, 11, 127 129.
17. Lees, P. Aliabadi, F.S. (2002) Rational dosing of antimicrobial drugs: animals versus humans. International Journal of Antimicrobial Agents, 19, 269 284.
18. Lode, H., Borner, K. Koeppe, P. (1998) Pharmacodynamics of fluoroquinolones. Clinical Infectious Diseases, 27, 33 39.
19. McKellar, Q.A., Gibson, I.F. McCormack, R.Z. (1998) Pharmacokinetics and Tissue disposition of danofloxacin in sheep. Biopharmaceutics & Drug Disposition, 19, 123 129.
20. Nix, D.E., Goodwin, D.D., Peloquin, C.A., Rotella, D.L. Schentag, J.J. (1991) Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response. Antimicrobial Agents and Chemotherapy, 35, 1953 1959.
21. Norcia, L.J.L., Silvia, A.M. Hayashi, S.F. (1999) Studies on time-kill kinetics of different classes of antibiotics against veterinary pathogenic bacteria including Pasteurella, Actinobacillus and Escherichia coli. Journal of Antibiotics, 52, 52 60.
22. Petracca, K., Riond, J.L., Graser, T. Tanner, M. (1993) Pharmacokinetics of the gyrase inhibitor marbofloxacin: influence of pregnancy and lactation in sows. Journal of Veterinary Medicine (A), 40, 73 79.
23. Pulido, M.M., Molina, A.J., Merino, G., Mendoza, G., Prieto, J.G. Alvarez, A.I. (2006) Interaction of enrofloxacin with breast câncer resistance protein (BCRP/ABCG2): influence of flavonoids and role in milk secretion in sheep. Journal of Veterinary Pharmacology and Therapeutics, 29, 279 287.
24. Sarasola, P., Less, P., AliAbadi, F.S., McKellar, Q.A., Donachie, W., Marr, K.A., Sunderland, S.J. Rowan, T.G. (2002) Pharmacokinetic and pharmacodynamic profiles of danofloxacin administered by two dosing regimens in calves infected with Mannheimia (Pasteurella) haemolytica. Antimicrobial Agents and Chemotherapy, 46, 3013 3019.
25. Schneider, M., Vallé, M., Woehrlé, F. Boisramé, B. (2004) Pharmacokinetics of marbofloxacin in lactating cows after repeated intramuscular administrations and pharmacodynamics against mastitis isolated strains. Journal of Dairy Science, 87, 202 211.
26. Schrickx, J.A. Fink-Gremmels, J. (2007) Danofloxacin-mesylate is a substrate for ATP-dependent efflux transporters. British Journal of Pharmacology, 150, 463 469.
27. Shem-Tov, M., Ziv, G., Glickman, A. Saran, A. (1997) Pharmacokinetics and penetration of danofloxacin from the blood into the milk of ewes. Veterinary Research, 28, 571 579.
28. Shem-Tov, M., Rav-Hon, O., Ziv, G., Lavi, E., Glickman, A. Saran, A. (1998) Pharmacokinetics and penetration of danofloxacin from the blood into the milk of cows. Journal of Veterinary Pharmacology and Therapeutics, 21, 209 213.
29. Soback, S., Gips, M., Bialer, M. Bor, A. (1994) Effect of lactation on single dose pharmacokinetics of norfloxacin in ewes. Antimicrobial Agents and Chemotherapy, 38, 2336 2339.
30. Ziv, G. (1980) Drug selection and use in mastitis: systemic vs. local therapy. Journal of the American Veterinary Medical Association, 176, 1109 1115.